Steven Van Laere

28.1k citations

161 papers · 5.6k indexed · h-index 45

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 72
- Cancer Genomics and Diagnostics 23
- Breast Cancer Treatment Studies 17
- Cancer-related molecular mechanisms research 14
Oncology 95
- Cancer Cells and Metastasis 37
- Cancer Immunotherapy and Biomarkers 17
- HER2/EGFR in Cancer Research 13

Co-authors: Luc Dirix Peter A. van Dam Peter Vermeulen Ilse Van der Auwera Gert G. Van den Eynden Eric A. Van Marck Cécile Colpaert François Bertucci
Journals: Cancer Research (17 papers)British Journal of Cancer (17 papers)Breast Cancer Research and Treatment (11 papers)PLoS ONE (8 papers)Clinical Cancer Research (7 papers)
Partner nations: Belgium United States France

In The Last Decade

Steven Van Laere

157 papers receiving 5.5k citations

Peers

Countries citing papers authored by Steven Van Laere

Since Specialization

Citations

This map shows the geographic impact of Steven Van Laere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Van Laere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Van Laere more than expected).

Fields of papers citing papers by Steven Van Laere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Van Laere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Van Laere. The network helps show where Steven Van Laere may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Van Laere, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Van Laere Line = papers co-authored together Steven Van Laere links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma OncoImmunology ·Sophie Rovers, Jonas R.M. Van Audenaerde, Ruben Verloy, Jorrit De Waele, Louize Brants, Christophe Hermans, Ho Wa Lau, Céline Merlin, Maria Ribas, Peter Ponsaerts, Steven Van Laere, Filip Lardon, An Wouters, Scott Fisher, Jan P. van Meerbeeck, Elly Marcq, Evelien Smits	2025	0
2	The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease International Journal of Obesity ·Annelies Van Eyck, Wilhelmus J. Kwanten, Cédric Peleman, Sanae Makhout, Steven Van Laere, Karolien Van De Maele, Kim Van Hoorenbeeck, Joris De Man, Benedicte Y. De Winter, Sven Francque, Stijn Verhulst	2023	6
3	Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner Cell Reports ·Guerman Molostvov, Mariam Gachechiladze, Abeer M. Shaaban, Steven Hayward, Isaac Dean, Irundika H.K. Dias, Nahla Badr, Irini Danial, Fiyaz Mohammed, Vera Novitskaya, Liliia Paniushkina, Valerie Speirs, Andrew M. Hanby, Irina Nazarenko, David R. Withers, Steven Van Laere, Heather M. Long, Fedor Berditchevski	2023	12
4	Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC npj Breast Cancer ·Charlotte Rypens, François Bertucci, Pascal Finetti, Fredika M. Robertson, Sandra V. Fernandez, Naoto T. Ueno, Wendy A. Woodward, Kenneth van Golen, Peter Vermeulen, Luc Dirix, Patrice Viens, Daniel Birnbaum, Gayathri R. Devi, Massimo Cristofanilli, Steven Van Laere	2022	4
5	L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases Laboratory Investigation ·Raymond L. Barnhill, Steven Van Laere, Peter Vermeulen, Sergio Roman‐Roman, Sophie Gardrat, Samar Alsafadi, Malcy Tarin, Gabriel Champenois, Nicolás André, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Manuel Rodrigues, Richard A. Scolyer, Alexander J. Lazar, Emanuela Romano, Sophie Piperno‐Neumann, Pascale Mariani, Claire Lugassy	2022	9
6	Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion Molecular Oncology ·Emilly S. Villodre, Xiaoding Hu, Richard Larson, Pascal Finetti, Kristen Gomez, Wintana Balema, Shane R. Stecklein, Ginette S. Santiago-Sánchez, Savitri Krishnamurthy, Juhee Song, Xiaoping Su, Naoto T. Ueno, Debu Tripathy, Steven Van Laere, François Bertucci, Pablo E. Vivas‐Mejía, Wendy A. Woodward, Bisrat G. Debeb	2021	27
7	Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis Clinical Cancer Research ·Amanda Fitzpatrick, Marjan Iravani, Adam Mills, Lucy Childs, Thanussuyah Alaguthurai, Angela Clifford, Isaac García-Murillas, Steven Van Laere, Luc Dirix, Mark Harries, Alicia Okines, Nicholas C. Turner, Syed Haider, Andrew Tutt, Clare M. Isacke	2021	44
8	miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial European Journal of Preventive Cardiology ·Andreas B. Gevaert, Isabel Witvrouwen, Amaryllis H. Van Craenenbroeck, Steven Van Laere, Jente R. A. Boen, Caroline M. Van De Heyning, Evgeny Belyavskiy, Stephan Mueller, Ephraim B. Winzer, André Duvinage, Frank Edelmann, Paul Beckers, Hein Heidbüchel, Ulrik Wisløff, Burkert Pieske, Volker Adams, Martin Halle, Emeline M. Van Craenenbroeck, (unknown)	2021	18
9	Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy Cancers ·Gayathri R. Devi, Pascal Finetti, Michael A. Morse, Seayoung Lee, Alexandre de Nonneville, Steven Van Laere, Jesse D. Troy, Joseph Geradts, Shannon J. McCall, François Bertucci	2021	22
10	The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Cancers ·Christophe Van Berckelaer, Iris Vermeiren, Leonie Vercauteren, Charlotte Rypens, Gizem Öner, Xuan Bich Trinh, Wiebren Tjalma, Glenn Broeckx, Emmanuelle Charafe‐Jauffret, Steven Van Laere, François Bertucci, Cécile Colpaert, Peter A. van Dam	2021	11
11	Identification of Macrophage Genotype and Key Biological Pathways in Circulating Angiogenic Cell Transcriptome Stem Cells International ·Bert Everaert, Steven Van Laere, Robrecht Lembrechts, Vicky Y. Hoymans, Jean‐Pierre Timmermans, Christiaan Vrints	2019	3
12	HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques PLoS ONE ·Anja Brouwer, Bram De Laere, Pieter‐Jan van Dam, Dieter Peeters, Jasper Van Haver, Ellen Sluydts, Ali El Moussaoui, Pauline A.J. Mendelaar, Jaco Kraan, Marc Peeters, Steven Van Laere, Luc Dirix	2019	9
13	XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype Cancer Research ·Myron K. Evans, Michael C. Brown, Joseph Geradts, Xuhui Bao, Timothy J. Robinson, Mohit Kumar Jolly, Peter Vermeulen, Gregory M. Palmer, Matthias Gromeier, Herbert Levine, Michael A. Morse, Steven Van Laere, Gayathri R. Devi	2018	44
14	Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer PLoS ONE ·Arvind Bambhroliya, Renae D. Van Wyhe, Swaminathan Kumar, Bisrat G. Debeb, Jay P. Reddy, Steven Van Laere, Randa El‐Zein, Arvind Rao, Wendy A. Woodward	2018	18
15	Disulfiram (DSF) acts as a copper ionophore to induce copper‐dependent oxidative stress and mediate anti‐tumor efficacy in inflammatory breast cancer Molecular Oncology ·Jennifer L. Allensworth, Myron K. Evans, François Bertucci, Amy J. Aldrich, Richard A. Festa, Pascal Finetti, Naoto T. Ueno, Rachid Safi, Donald P. McDonnell, Dennis J. Thiele, Steven Van Laere, Gayathri R. Devi	2015	193
16	Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer Cancer Research ·Maurice P.H.M. Jansen, Theo Knijnenburg, Esther A. Reijm, Iris Simón, Ron Kerkhoven, Marjolein Droog, Arno Velds, Steven Van Laere, Luc Dirix, Xanthippi Alexi, John A. Foekens, Lodewyk F.A. Wessels, Sabine C. Linn, Els M.J.J. Berns, Wilbert Zwart	2013	57
17	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen Breast Cancer Research and Treatment ·Diana Ramirez-Ardila, Jean Helmijr, Maxime P. Look, Irene Lurkin, Kirsten Ruigrok-Ritstier, Steven Van Laere, Luc Dirix, Fred C.G.J. Sweep, Paul N. Span, Sabine C. Linn, John A. Foekens, Stefan Sleijfer, Els M.J.J. Berns, Maurice P.H.M. Jansen	2013	43
18	Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase Molecular Cancer Research ·Heather L. Lehman, Steven Van Laere, Cynthia M. van Golen, Peter Vermeulen, Luc Dirix, Luc Van Kaer	2012	48
19	Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer Clinical Cancer Research ·Gert G. Van den Eynden, Marcel Smid, Steven Van Laere, Cécile Colpaert, Ilse Van der Auwera, Trinh Xuan Bich, Peter A. van Dam, Michael A. den Bakker, Luc Dirix, Eric A. Van Marck, Peter Vermeulen, John A. Foekens	2008	23
20	Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer Clinical Cancer Research ·Steven Van Laere, Tim Beißbarth, Ilse Van der Auwera, Gert Van den Eynden, Xuan Bich Trinh, Hilde Elst, Paul Van Hummelen, Peter A. van Dam, Eric Van Marck, Peter Vermeulen, Luc Dirix	2008	24

About Steven Van Laere

Steven Van Laere is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 161 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (37 papers), Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (17 papers), Breast Cancer Treatment Studies (17 papers), Angiogenesis and VEGF in Cancer (16 papers), Cancer-related molecular mechanisms research (14 papers), HER2/EGFR in Cancer Research (13 papers) and Estrogen and related hormone effects (11 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.7k citations), Molecular Biology (2.6k citations), Pulmonary and Respiratory Medicine (968 citations) and Immunology (494 citations). Steven Van Laere has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Luc Dirix, Peter A. van Dam, Peter Vermeulen, Ilse Van der Auwera, Gert G. Van den Eynden, Peter Vermeulen, Eric A. Van Marck, Cécile Colpaert, François Bertucci and Luc Dirix. Their work appears in journals such as Cancer Research, British Journal of Cancer, Breast Cancer Research and Treatment, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact